Skip to Content

Fidelity Advisor Biotechnology I FBTIX Fund Analysis

| Medalist Rating as of | See Fidelity Investment Hub

Morningstar’s Analysis FBTIX

Will FBTIX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

An upgrade in its Process Pillar rating is the primary driver of Fidelity Advisor Biotechnology I's upgrade to a Morningstar Medalist Rating of Silver from Bronze.

null Morningstar Manager Research

Morningstar Manager Research

Summary

The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor